Pre-biopsy prostate-specific antigen velocity does not predict gleason score, tumor location or cancer volume following transperineal-template guided prostate mapping biopsy: Implications for prostate brachytherapy treatment planning

被引:1
|
作者
Bittner, N. [1 ]
Merrick, G. S. [2 ]
Wallner, K. E. [3 ]
Butler, W. M. [2 ]
Anderson, R. L. [2 ]
Allen, Z. A. [2 ]
Adamovich, E. [4 ]
机构
[1] Univ Washington, Seattle, WA 98195 USA
[2] Schiffler Canc Ctr, Wheeling, WV USA
[3] Puget Sound Healthcare Corp, Seattle, WA USA
[4] Wheeling Hosp, Dept Pathol, Wheeling, WV USA
关键词
D O I
10.1016/j.ijrobp.2008.06.1132
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S334 / S334
页数:1
相关论文
共 48 条
  • [31] Magnetic Resonance Imaging-Based Prostate-Specific Antigen Density for Prediction of Gleason Score Upgrade in Patients With Low-Risk Prostate Cancer on Initial Biopsy
    Sim, Ki Choon
    Sung, Deuk Jae
    Kang, Kun Woo
    Yang, Kyung Sook
    Han, Na Yeon
    Park, Beom Jin
    Kim, Min Ju
    Cho, Sung Bum
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2017, 41 (05) : 731 - 736
  • [32] Prospective study of pre-biopsy magnetic resonance imaging (mpMRI) compared to transperineal template mapping biopsy (TTMB) for detection of clinically significant prostate cancer: is it accurate enough to guide selection of men for biopsy?
    Thompson, J.
    Shnier, R.
    Moses, D.
    Brenner, P.
    Delprado, W.
    Tran, M.
    Bohm, M.
    Pulbrook, M.
    Hayen, A.
    Stricker, P.
    BJU INTERNATIONAL, 2015, 115 : 37 - 37
  • [33] Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin tables) based on cases from 2000 to 2005
    Makarov, D., V
    Trock, B. J.
    Humphreys, E. B.
    Mangold, L. A.
    Walsh, P. C.
    Epstein, J., I
    Partin, A. W.
    Kattan, Michael W.
    EUROPEAN UROLOGY, 2007, 52 (05) : 1528 - 1528
  • [34] Prospective study of pre-biopsy multiparametric magnetic resonance imaging (mpMRI) compared to transperineal template mapping biopsy (TTMB) for detection of clinically significant prostate cancer: is it accurate enough to guide selection of men for biopsy?
    Thompson, James
    van Leeuwen, Pim
    Shnier, Ron
    Moses, Daniel
    Brenner, Phillip
    Delprado, Warick
    Boehm, Maret
    Hayen, Andrew
    Stricker, Phillip
    BJU INTERNATIONAL, 2015, 116 : 29 - 29
  • [35] PROSPECTIVE STUDY OF PRE-BIOPSY MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING (MPMRI) COMPARED TO TRANSPERINEAL TEMPLATE MAPPING BIOPSY (TTMB) FOR DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: IS IT ACCURATE ENOUGH TO GUIDE SELECTION OF MEN FOR BIOPSY?
    Thompson, James
    Shnier, Ron
    Moses, Daniel
    Brenner, Phillip
    Delprado, Warick
    Tran, Minh
    Ponsky, Lee
    Boehm, Maret
    Hayen, Andrew
    Stricker, Phillip
    JOURNAL OF UROLOGY, 2015, 193 (04): : E959 - E959
  • [36] The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume
    Corcoran, Niall M.
    Casey, Rowan G.
    Hong, Matthew K. H.
    Pedersen, John
    Connolly, Stephen
    Peters, Justin
    Harewood, Laurence
    Gleave, Martin E.
    Costello, Anthony J.
    Hovens, Chris M.
    Goldenberg, S. Larry
    BJU INTERNATIONAL, 2012, 110 (01) : 36 - 42
  • [37] Editorial Comment to predicting the probability significant prostate cancer in Japanese men with serum prostate-specific antigen less than 10 ng/mL: Development of a novel pre-biopsy nomogram
    Yamamoto, Shinya
    INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 (03) : 280 - 280
  • [38] Can transrectal ultrasound-guided biopsy of the prostate with extended 14-core scheme improve the predictive accuracy of Gleason score and tumor site in prostate cancer treatment?
    Dell'Atti, Lucio
    JOURNAL OF BUON, 2015, 20 (05): : 1239 - 1243
  • [39] Pre-biopsy PSA and highest percentage of cancer (hPCA) on prostate biopsy can adequately predict upgrading of gleason score (GS) on subsequent prostatectomy: A single institution study in a cohort of patient with GS 6
    Venkataraman, G.
    Rycyna, K.
    Flanigan, R. C.
    Wojcik, E. M.
    MODERN PATHOLOGY, 2007, 20 : 344A - 344A
  • [40] Pre-biopsy PSA and highest percentage of cancer (hPCA) on prostate biopsy can adequately predict upgrading of Gleason Score (GS) on subsequent prostatectomy: A single institution study in a cohort of patient with GS 6
    Venkataraman, G.
    Rycyna, K.
    Flanigan, R. C.
    Wojcik, E. M.
    LABORATORY INVESTIGATION, 2007, 87 : 344A - 344A